The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Clearance of irretrievable bile duct and pancreatic duct stones by extracorporeal shockwave lithotripsy, using a transportable device: effectiveness and medium-term results

 

Conigliaro R, Camellini L, Zuliani CG, Sassatelli R, Mortilla MG, Bertoni G, Formisano D, Bedogni G.

 

J Clin Gastroenterol. Mar;40(3):213-9

2006

 

Efficient cold transfection of pea ferredoxin-NADP(H) oxidoreductase into rat hepatocytes

Mediavilla MG, Krapp A, Carrillo N, Rodríguez JV, Tiribelli C, Guibert EE.

J Gene Med., Mar;8(3):306-13

2006

 

Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity

Calligaris S, Cekic D, Roca-Burgos L, Gerin F, Mazzone G, Ostrow JD, Tiribelli C.

FEBS Lett. Feb 20;580(5):1355-9. Epub 2006 Jan 26.

2006

 

Cross validation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children

Brambilla P, Bedogni G, Moreno LA, Goran MI, Gutin B, Fox KR, Peters DM, Barbeau P, De Simone M, Pietrobelli A.

Int J Obes (Lond), Jan;30(1):23-30. Review

2006

 

Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results

Bertolotto M, Pozzato G, Crocè LS, Nascimben F, Gasparini C, Cova MA, Tiribelli C.

Invest Radiol. Jan;41(1):15-21

2006

 

Vagaries of impaired transporter function in PFIC 2 & 3 (Letter to the Editor)

Ostrow JD and Tiribelli C.

Hepatology, Oct, 42:977-978

2005

Prevalence of and risk factors for non alcoholic fatty liver disease: The Dionysos nutrition and liver study

Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, and Bellentani S.

Hepatology, Jul, 42:44-52.

2005

 

Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver

Cesaratto L, Vascotto C, D’Ambrosio C, Scaloni A, Baccarani U, Paron I, Damante G, Calligaris S, Quadrifoglio F, Tiribelli C and Tell G.

Free Radical Research, Mar, 39:255-268.

2005

 

The human Multidrug Resistance-associated Protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin

Rigato I, Pascolo L, Fernetti C, Ostrow JD and Tiribelli C.

Biochem.Journal, Oct, 383:335-341

2004

 

Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents

Bedogni G, Miglioli L, Masutti F, Castiglione A, Tiribelli C and Bellentani S.

Ann.Human Biol. , Sep-Oct, 31:570-577

2004

 

Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?

Bellarosa C, Vitek L, Tiribelli C

Clin Pharmacol Ther. Dec 27. doi: 10.1002/cpt.1341

2018

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. Jun;67(6):2072-2073. doi: 10.1002/hep.29753.

2018

A new stage in Annals of Hepatology

Panduro A, Tiribelli C, Chávez-Tapia NC, Uribe M

Ann Hepatol. 17(3):339-340. doi: 10.5604/01.3001.0011.7377.

2018

Where do we stand in the field of neonatal jaundice? Commentary on the 2017 J. Donald Osrow Trieste Yellow Retreat

Riordan S, Gazzin S

Pediatr Res. Jun;83(6):1090-1092. doi: 10.1038/pr.2018.53.

2018

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.

2017

Treatments for non-alcoholic steatohepatitis - still a long way to go

 Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)

2017